Navigation Links
Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Release of Emails from Johnson & Johnson’s Janssen Subsidiary in Federal Risperdal Settlement
Date:11/17/2013

New York, New York (PRWEB) November 17, 2013

As Risperdal lawsuits (http://www.therisperdallawsuit.com/ ) over allegations that use of drug may cause gynecomastia, or male breast growth, continue to move forward, Bernstein Liebhard LLP notes that the U.S. Department of Justice has released several internal emails from Johnson & Johnson’s Janssen Pharmaceutical subsidiary that raise questions about the company’s disclosure of Risperdal clinical trial data. In one such email from 2003, a researcher expresses concern about “clinical trial data the company has been sitting on since for a long time,” and urges Janssen to “publish not just the clinical efficacy data which should very well be informative and supportive of the use of” Risperdal, but “also the safety data, including events that have been labeled in the past as ‘cerbrovascular adverse events’ and death.”*

According to Bernstein Liebhard, another email from 2004 seems to indicate that Janssen may have been reluctant to disclose unfavorable data from another Risperdal study. “At this point, we must be concerned that this gives the strong appearance that Janssen is purposely witholding (sic) the findings from RIS 232,” the writer warns. “I really do have to speak out and urge that Janssen avoids embarrassment and accusations about suppressing information that is relevant to providers and consumers.**

“A number of Risperdal lawsuits, including many that involve gynecomastia, have been filed in recent years that allege Johnson & Johnson and Janssen concealed Risperdal side effects. Considered in that light, these emails are very interesting,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Risperdal lawsuit consultations to any individual who may have develop
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Parker Waichman LLP Commends Arkansas Attorney General for Backing Fine Against Johnson & Johnson over Risperdal Off-Label Marketing Allegations
2. The Consumer Justice Foundation Launches RisperdalLaw.com, an Informational Web Site Dealing with Alleged Risperdal Side Effects Including Gynecomastia
3. Bernstein Liebhard LLP Investigating Risperdal Lawsuits on Behalf of Victims of Male Breast Growth Allegedly Caused by Risperdal
4. New Risperdal Lawsuit Filed in Pennsylvania Litigation; Alleges Male Breast Growth Injuries Caused by Anti-Psychotic Medication, Bernstein Liebhard LLP Reports
5. Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Settlement in Risperdal Marketing Investigation
6. Risperdal Lawsuits: $2.2 Billion Settlement Between Federal Government, Johnson & Johnson Over Alleged Illegal Marketing of Risperdal, Other Medications
7. Risperdal Lawsuit News: Johnson & Johnson To Pay Over $2.2 Billion In Risperdal and Invega Settlement Draws Comment From Wright & Schulte LLC
8. J&J to Pay $2.2B to Settle Allegations Over Its Marketing of Risperdal; Parker Waichman LLP Applauds Efforts of Whistleblowers in Helping Compel Resolution
9. Risperdal Lawsuit News: Rottenstein Law Group LLP Comments on $2 Billion Risperdal Settlement Report
10. Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Mounting Claims Involving Risperdal Gynecomastia Allegations in Pennsylvania Litigation
11. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... To sexually objectify a woman is to focus on ... sexual pleasure rather than viewing her as a complete ... long been considered a problem in the media, how ... in Psychology of Women Quarterly , a SAGE ... body is related to higher incidents of sexual pressure ...
(Date:8/21/2014)... London, UK (PRWEB) August 21, 2014 ... from USD 15.6 billion in 2014 and reach USD ... during the forecast period. The drivers of such growth ... products, rising obese and diabetic population, and surging ageing ... costs of state-of-the-art wound care products. Region-wise, North America ...
(Date:8/21/2014)... Revista, a one-stop source for healthcare ... is “on a roll.” Today, the Annapolis-based company ... Southeast, Mid-Atlantic and Midwest areas of the country ... available, comprehensive medical property database tracking these regions. ... including existing and recently added, is 34,549. This ...
(Date:8/21/2014)... News) -- Using two types of polio vaccines seems ... boost efforts to eradicate polio, a new study shows. ... found that giving the Salk inactivated poliovirus vaccine (IPV) ... live-attenuated oral poliovirus vaccine (OPV) appeared to improve their ... findings, reported in the Aug. 22 issue of the ...
(Date:8/21/2014)... (CHEST) announces the immediate release of Care of ... Disasters: CHEST Consensus Statement today in the Online ... while the global health-care community cares for patients ... to guide ethical decision-making, coordination of care, resource ... developed by over 100 clinicians and experts representing ...
Breaking Medicine News(10 mins):Health News:Objectification in romantic relationships related to sexual pressure and coercion 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 3Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 2Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 3Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 4Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 5Health News:Two Polio Vaccines May Give Greater Protection Against Crippling Disease 2Health News:CHEST releases new expert guidance in care of the critically ill and injured 2
... PHILADELPHIA, Sept. 28 Independence Blue Cross,announces it ... System,and St. Mary Medical Center, both part of ... 2007. The Mercy Health System includes Mercy ... St. Agnes Continuing,Care Center, and Nazareth Hospital, as ...
... Intelligence,executive once said: "CI is like oxygen. You have ... need it is when it is in short supply." ... or have been a,client for such insights, you understand ... position in the,marketplace. By delivering high-impact analyses on competitors, ...
... New Option To Treat Morbid Obesity, CINCINNATI, ... U.S. Food and Drug Administration (FDA) approved for,marketing ... for,weight reduction and improvement in obesity-related health conditions, ... obesity. The REALIZE Band is an innovative ...
... BOZEMAN, Mont. -- Stable flies are the latest suspect that ... hundreds of pelican chicks at the Medicine Lake National Wildlife ... 1,000 pelican chicks in 2003, averaged 400 in each of ... year. , Veterinary entomologist Greg Johnson of Montana State University ...
... that minority patients generally receive a lower quality ... can these disparities be reduced? A supplement to ... and Review, published by SAGE, thoroughly explores the ... question. , The supplement features research from the ...
... ON, Sept. 28 /PRNewswire-FirstCall/ - AlphaRx Inc. (OTC ... the next,generation of therapeutic products for inflammatory and ... million of,liabilities. Pursuant to a unanimous resolution ... to the Company by its directors, officers and ...
Cached Medicine News:Health News:Independence Blue Cross Finalizes New Multi-Year Agreements with Mercy Health System and St. Mary Medical Center 2Health News:Independence Blue Cross Finalizes New Multi-Year Agreements with Mercy Health System and St. Mary Medical Center 3Health News:Uncover Key Competitive Intelligence Insights in Webinars Hosted by Best Practices 2Health News:FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity 2Health News:FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity 3Health News:FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity 4Health News:Montana State University researchers investigate new suspect in West Nile deaths of pelicans 2
(Date:8/21/2014)... 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ), ... that it has completed integration with Nextech, a ... Surgery and Dermatology practices. "Integration allows ... healthcare practices using Nextech," stated Bob Fabbio ... information from the EMR we are able to ...
(Date:8/21/2014)... , Aug. 21, 2014 The spinal column ... the human body. Signals carried to and from the brain ... skills and nervous system. Injury or ailment here can be ... with a loss of control over their body. Though back ... a person,s life, there are more options available to make ...
(Date:8/21/2014)... -- Publicis Groupe customer engagement agency Rosetta today ... Industry Group Leader, has been featured in the 2014 ... people in the life-sciences industry. Those chosen for this ... technology, creativity, strategy and medicine. Hartley ... its leading Rosetta Consulting practice. In 2012, she was ...
Breaking Medicine Technology:eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Shannon Hartley Shines in PharmaVOICE 100 2
... ROSA, Calif. , Feb. 16 Osseon Therapeutics Inc. ... Europe . The procedures were performed in Milan, Italy . ... independent medical device distributor in Europe , Osseoplasty cases are ... United Kingdom , Germany and Spain . , ...
... N.J. , Feb. 16 IntegriChain, Inc., ... the launch of its new DNA: Dynamic NextGen ... helps pharmaceutical manufacturers unlock the value of Direct Data ... Data includes those data assets typically provided to ...
Cached Medicine Technology:Osseon Launches in Europe 2IntegriChain Launches DNA: Dynamic NextGen Analytics(TM) Platform 2IntegriChain Launches DNA: Dynamic NextGen Analytics(TM) Platform 3
DSL-10-49200 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in serum. This kit requires no sample extraction or pretreatment...
RIA kit for the quantitative determination of autoantibodies to steroid 21-hydroxylase (21-OH) in serum....
... volume for use with 4, 8, or 12 ... withdrawal of nearly all of the solution. Corners ... Made of natural virgin polystyrene containing no regrinds. ... by irradiation. Dimensions: 78 mm W x 152 ...
... Increased volume for use with 4, ... and V-shaped bottom permits withdrawal of nearly ... lips to dispose of excess solution. Made ... Non-sterile. Dimensions: 78 mm W x 152 ...
Medicine Products: